FDA strengthens medical device cybersecurity program
Continuous glucose, the 5th vital sign, now available as part of the Current Health platform. Learn more about our partnership with Dexcom.

“The FDA can’t solve this problem on their own; the device developers have to do it,” McCann said. “What the FDA can do is make sure we all consider it as a top priority and we keep considering it a top priority even once the device is out there.”